Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells

Amith Panner1, Leanne L Cribbs, Gina M Zainelli

  • 1Department of Neurological Surgery and The Brain Tumor Research Center, University of California San Francisco, San Francisco, CA 94115, USA. apanner@cc.ucsf.edu

Cell Calcium
|December 14, 2004
PubMed

Insights

T-type calcium channels regulate cell division in glioma and neuroblastoma cells. Blocking these channels, or reducing their subunits, inhibits proliferation, while increasing alpha1H subunits boosts cell division.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • T-type calcium channels are implicated in various cellular functions.
  • Their role in glioma and neuroblastoma cell proliferation requires further elucidation.

Purpose of the Study:

  • To investigate the involvement of T-type calcium channels in the cell division of U87MG glioma and N1E-115 neuroblastoma cells.
  • To determine the impact of alpha1G and alpha1H T-type calcium channel subunits on cell proliferation.

Main Methods:

  • Western blot analysis to assess protein expression levels.
  • Utilized serum starvation and mibefradil (a T-type calcium channel antagonist) to modulate channel activity.
  • Employed gene manipulation techniques including subunit overexpression and antisense oligonucleotides to alter subunit expression.

Main Results:

  • Decreased expression of alpha1G and alpha1H subunits correlated with reduced cell proliferation and increased cyclin D1 levels.
  • Serum starvation and mibefradil treatment led to significant downregulation of alpha1G/alpha1H and upregulation of cyclin D1.
  • Overexpression of alpha1H subunit doubled cell proliferation, while antisense inhibition of alpha1G subunit reduced proliferation by 70%.

Conclusions:

  • T-type calcium channel expression, specifically alpha1G and alpha1H subunits, plays a critical role in regulating the proliferation of U87MG glioma and N1E-115 neuroblastoma cells.
  • These findings highlight T-type calcium channels as potential therapeutic targets for glioma and neuroblastoma treatment.